Trippler, Martin

Publishing since 2002 (Junior)

Has published 10 publications in 8 years

Number of publications published per year by Trippler, Martin. (Source : PubMed)

Distribution of publications types for Trippler, Martin. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Wang B, Trippler M, Pei R, Lu M, Broering R, Gerken G, Schlaak JF. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.  J. Hepatol.  2009;51;6  
•  Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, Bucchi A, Krux F, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.  Immunology  2009  
•  Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R, Bucchi A, Sowa JP, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.  Hepatology  2009;49;4  
•  Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, Szczeponek A, Gerken G, Schlaak JF. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.  J. Hepatol.  2008;48;6  
•  Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A, Krux F, Dittmer U, Roggendorf M, Gerken G, Schlaak JF. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.  Hepatology  2007;46;6  
•  Bockhorn M, Schöllmann S, Opitz B, Sotiropoulos GC, Sheu SY, Niehaus E, Trippler M, Frilling A, Broelsch CE, Schlaak JF. Vascular endothelial growth factor does not improve liver regeneration and survival after 90% subtotal liver resection.  Hepatol. Res.  2007;37;5  
•  Bockhorn M, Goralski M, Prokofiev D, Dammann P, Grünewald P, Trippler M, Biglarnia A, Kamler M, Niehues EM, Frilling A, Broelsch CE, Schlaak JF. VEGF is important for early liver regeneration after partial hepatectomy.  J. Surg. Res.  2007;138;2  
•  Windisch MP, Frese M, Kaul A, Trippler M, Lohmann V, Bartenschlager R. Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line.  J. Virol.  2005;79;21  
•  Beckebaum S, Malagó M, Dirsch O, Cicinnati VR, Trippler M, Lampertico P, Lama N, Treichel U, Gerken G, Broelsch CE. Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation.  Clin Transplant  2003;17;6  
•  Karliova M, Malago M, Trippler M, Valentin-Gamazo C, Rothaar T, Broelsch CE, Gerken G, Treichel U. Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin.  Transplant. Proc.  2002;34;8  

[ See timeline ] [ See all publications ]